Literature DB >> 17047674

Implication of abnormal epigenetic patterns for human diseases.

C B Santos-Rebouças1, M M G Pimentel.   

Abstract

Significant evidences have brought new insights on the mechanisms by which epigenetic machinery proteins regulate gene expression, leading to a redefinition of chromatin regulation in terms of modification of core histones, DNA methylation, RNA-mediated silencing pathways, action of methylation-dependent sensitive insulators and Polycomb/Trithorax group proteins. Consistent with these fundamental aspects, an increasing number of human pathologies have been found to be associated with aberrant epigenetics regulation, including cancer, mental retardation, neurodegenerative symptoms, imprinting disorders, syndromes involving chromosomal instabilities and a great number of human life-threatening diseases. The possibility of reversing epigenetic marks, in contrast to genetic code, may provide new pharmacological targets for emerging therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047674     DOI: 10.1038/sj.ejhg.5201727

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  32 in total

Review 1.  Phytochemical antioxidants modulate mammalian cellular epigenome: implications in health and disease.

Authors:  Smitha Malireddy; Sainath R Kotha; Jordan D Secor; Travis O Gurney; Jamie L Abbott; Gautam Maulik; Krishna R Maddipati; Narasimham L Parinandi
Journal:  Antioxid Redox Signal       Date:  2012-04-17       Impact factor: 8.401

2.  Consolidation of the cancer genome into domains of repressive chromatin by long-range epigenetic silencing (LRES) reduces transcriptional plasticity.

Authors:  Marcel W Coolen; Clare Stirzaker; Jenny Z Song; Aaron L Statham; Zena Kassir; Carlos S Moreno; Andrew N Young; Vijay Varma; Terence P Speed; Mark Cowley; Paul Lacaze; Warren Kaplan; Mark D Robinson; Susan J Clark
Journal:  Nat Cell Biol       Date:  2010-02-21       Impact factor: 28.824

Review 3.  Epigenetic principles and mechanisms underlying nervous system functions in health and disease.

Authors:  Mark F Mehler
Journal:  Prog Neurobiol       Date:  2008-10-17       Impact factor: 11.685

4.  Altering TET dioxygenase levels within physiological range affects DNA methylation dynamics of HEK293 cells.

Authors:  Christian Grosser; Nicholas Wagner; Katrin Grothaus; Bernhard Horsthemke
Journal:  Epigenetics       Date:  2015-07-17       Impact factor: 4.528

5.  A novel method for detecting 7-methyl guanine reveals aberrant methylation levels in Huntington disease.

Authors:  Beena Thomas; Samantha Matson; Vanita Chopra; Liping Sun; Swati Sharma; Steven Hersch; H Diana Rosas; Clemens Scherzer; Robert Ferrante; Wayne Matson
Journal:  Anal Biochem       Date:  2013-02-12       Impact factor: 3.365

Review 6.  Beyond the histone tale: HP1α deregulation in breast cancer epigenetics.

Authors:  Johan Vad-Nielsen; Anders Lade Nielsen
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 7.  Active DNA demethylation: many roads lead to Rome.

Authors:  Susan C Wu; Yi Zhang
Journal:  Nat Rev Mol Cell Biol       Date:  2010-08-04       Impact factor: 94.444

8.  Epigenetics of programmed obesity: alteration in IUGR rat hepatic IGF1 mRNA expression and histone structure in rapid vs. delayed postnatal catch-up growth.

Authors:  Darran N Tosh; Qi Fu; Christopher W Callaway; Robert A McKnight; Isabella C McMillen; Michael G Ross; Robert H Lane; Mina Desai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-02       Impact factor: 4.052

9.  Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity.

Authors:  Elena Shumay; Joanna S Fowler; Nora D Volkow
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

10.  Histone H1x is highly expressed in human neuroendocrine cells and tumours.

Authors:  Julia Warneboldt; Florian Haller; Olaf Horstmann; Bernhard C Danner; László Füzesi; Detlef Doenecke; Nicole Happel
Journal:  BMC Cancer       Date:  2008-12-24       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.